Acura Pharmaceuticals, Inc. (ACUR)

OTCMKTS: ACUR · Delayed Price · USD
0.0004
0.00 (0.00%)
Sep 26, 2023, 4:00 PM EDT - Market closed
Market Cap 26.40K
Revenue (ttm) 1.56M
Net Income (ttm) -1.08M
Shares Out 66.00M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 262
Open 0.0004
Previous Close 0.0004
Day's Range 0.0004 - 0.0004
52-Week Range 0.0002 - 0.1000
Beta 2.21
Analysts n/a
Price Target n/a
Earnings Date Feb 28, 2020

About ACUR

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ... [Read more]

Sector Healthcare
Founded 1935
Employees 9
Stock Exchange OTCMKTS
Ticker Symbol ACUR
Full Company Profile

Financial Performance

In 2021, ACUR's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$1.08 million, -34.92% less than in 2020.

Financial Statements

News

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date Amendment Extends NDA Acceptance Date

1 year ago - GlobeNewsWire

Acura Pharmaceuticals Provides Development Update on LTX-03

PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and acetaminophen) tablets using Acura's LIMITx tech...

1 year ago - GlobeNewsWire

Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technolog...

2 years ago - GlobeNewsWire

Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technolog...

2 years ago - GlobeNewsWire